FDA 483 - Smithfield Bioscience Inc - December 23, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Smithfield Biosciences, Inc. in Cincinnati, OH, an API manufacturer, received a Form 483 with six observations during an inspection from December 16-23, 2025. The inspection revealed significant deficiencies in process validation, supplier qualification, quality unit review of records, investigation of discrepancies, personnel adequacy, and the stability program. These issues indicate a lack of robust quality control and compliance with GMP requirements for API manufacturing.
ID · 23bc4453-7c80-42e1-9453-30614e74e460